| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |